Bactiguard is a Swedish medtech company with a global presence, offering a infection protection solution that prevents healthcare associated infections caused by medical devices. By preventing healthcare associated infections, we reduce the use of antibiotics and thereby the spread of multi-resistant bacteria, which is a growing problem worldwide.
We save lives, increase patient safety and significantly reduce the cost of healthcare. Our technology is well-proven, safe and tissue friendly and consist of a thin layer of noble metals that prevent bacteria adhesion. The coating can be applied on almost any material used for medical devices. The company's product portfolio currently consist of catheters for the urinary tract, respiratory tract and the blood stream. Bactiguard coated urinary cathters are market leading in the US and Japan and the company has also a product portfolio of coated catheters for the urinary tract, respiratory tract and the blood stream.
Bactiguard is currently in a strong expansion phase, focused on markets in Europe, Middle East, Asia, South America and Southern Africa. The company is characterized by innovation, entrepreneurship, diversity, equality, a quick decision process and own responsibility. Today Bactiguard employs about 70 people around the world, mainly at the headquarters in Sweden and at the production facility in Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard on www.bactiguard.com